Concomitant administration of lenvatinib and camrelizumab for the treatment of hepatocellular carcinoma, and its effect on hepatocellular carcinoma control

نویسندگان

چکیده

Purpose: To study the efficacy of combined use lenvatinib and camrelizumab in hepatocellular carcinoma (HCC) therapy, its impact on disease control rate (DCR).
 Methods: The medical records 92 HCC patients treated at Oncology Department People’s Hospital Dongying, China (April 2019-April 2020), were chosen for analysis, assigned into group (SG, n = 46) reference (RG, based odd even hospital admission no. All received specific routine treatments. In addition, SG was with combination camrelizumab. After treatment, liver function levels serum tumor markers determined.
 Results: Compared RG, had significantly lower indices {alanine aminotransferase (ALT), total bilirubin (TBiL), aspartate (AST)} {alpha-fetoprotein (AFP), alpha-fetoprotein variant (AFP-L3) Golgi protein 73 (GP73)} (p < 0.001); higher DCR 0.05), score Eastern Cooperative Group (ECOG), Karnofsky (KPS) 0.001).
 Conclusion: may be a reliable strategy reducing marker patients, improving patients’ performance status, enhancing DCR.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma

Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...

متن کامل

Evaluation of Photoelectron Therapy Effect on Hepatocellular Carcinoma

Mofid B1, Navabpoor M2, Alizadeh Azimi M3 1. Assistant professor, Department of Radiotherapy, Faculty of Para-Medicine, Shahid Beheshti University of medical sciences 2. Instructor, Department of Technology of radiology, Faculty of Para-Medicine, Shahid Beheshti University of medical sciences Abstract Background: Photoelectron therapy method has been usad successfully, on the body phantom...

متن کامل

Lenvatinib in Advanced Hepatocellular Carcinoma.

Sorafenib has been the standard therapy for patients with unresectable hepatocellular carcinoma (HCC) since 2007, when it was shown to prolong survival, as verified in the SHARP trial [1] and a study conducted in the Asia-Pacific region [2] . Since then, other molecular-targeted agents superior to sorafenib in efficacy or safety in the first-line treatment of HCC were developed and tested in cl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Tropical Journal of Pharmaceutical Research

سال: 2022

ISSN: ['1596-5996', '1596-9827']

DOI: https://doi.org/10.4314/tjpr.v21i9.22